20 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18597717 | ORAL SOLID DOSAGE FORMS COMPRISING CANNABINOIDS | CHANG, KYUNG SOOK | 1613 | Non-Final OA | Mar 06, 2024 |
| 18560316 | 6-HYDROXY-CANNABIDIOL-C4 | HAVLIN, ROBERT H | 1626 | Non-Final OA | Nov 10, 2023 |
| 18560341 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | REILLY, SOPHIA JANE | 1627 | Non-Final OA | Nov 10, 2023 |
| 18477467 | PHARMACEUTICAL COMPOSITION COMPRISING A CANNABINOID | JAVANMARD, SAHAR | 1622 | Non-Final OA | Sep 28, 2023 |
| 18548003 | USE OF CANNABIDIOL AND CLOBAZAM IN THE TREATMENT OF CHILDHOOD-ONSET EPILEPSY SYNDROMES | MELLER, MICHAEL V | 1655 | Non-Final OA | Aug 25, 2023 |
| 18546254 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | BAUER, BRIANNA LEE | 1623 | Non-Final OA | Aug 11, 2023 |
| 18446405 | CANNABIDIOL PREPARATIONS AND ITS USES | JAVANMARD, SAHAR | 1622 | Non-Final OA | Aug 08, 2023 |
| 18257479 | A METHOD FOR EVALUATING THE PRO-OR ANTI CONVULSIVE PROPERTIES OF TEST COMPOUNDS | BAEK, JONGHWAN NMN | 1618 | Non-Final OA | Jun 14, 2023 |
| 18257373 | CANNABINOID DERIVATIVES AS PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHOD OF PREPARATION THEREOF | KIFLE, BRUCK | 1624 | Non-Final OA | Jun 14, 2023 |
| 18256307 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH EPILEPSY SYNDROMES IN PATIENTS TAKING BRIVARACETAM | PECKHAM, RICHARD GRANT | 1627 | Non-Final OA | Jun 07, 2023 |
| 18044941 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | ISMAIL, REHANA | 1625 | Non-Final OA | Mar 10, 2023 |
| 18006131 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO BRAIN INJURY | RAMACHANDRAN, UMAMAHESWARI | 1627 | Non-Final OA | Jan 19, 2023 |
| 18006129 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO STRUCTURAL ABNORMALITIES OF THE BRAIN | RAO, SAVITHA M | 1691 | Non-Final OA | Jan 19, 2023 |
| 18006121 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | RAO, SAVITHA M | 1691 | Non-Final OA | Jan 19, 2023 |
| 18005868 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CHRNA4 MUTATION | JAVANMARD, SAHAR | 1622 | Non-Final OA | Jan 18, 2023 |
| 18005843 | USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | MERCIER, MELISSA S | 1615 | Final Rejection | Jan 17, 2023 |
| 17786949 | ORAL CANNABINOID FORMULATIONS | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | Non-Final OA | Jun 17, 2022 |
| 17771184 | (-) - CIS TETRAHYDROCANNABINOL ((-) - CIS-THC) FOR USE AS A MEDICAMENT | NESTOR, DONNA MICHELLE | 1627 | Final Rejection | Apr 22, 2022 |
| 17771195 | (+)-TRANS TETRAHYDROCANNABINOL ((+)-TRANS-THC) FOR USE AS A MEDICAMENT | NESTOR, DONNA MICHELLE | 1627 | Final Rejection | Apr 22, 2022 |
| 17771190 | (+)-CIS TETRAHYDROCANNABINOL ((+)-CIS-THC) FOR USE AS A MEDICAMENT | NESTOR, DONNA MICHELLE | 1627 | Final Rejection | Apr 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial